In TNBC, PFD inhibits the TGF-β/Smad signaling pathway, reducing the expression of EMT-related transcription factors and mesenchymal genes, inhibiting breast cancer cell proliferation, migration, and invasion, and promoting apoptosis. This evidence concerns the gene TGFB1 and breast carcinoma.